Economic Benefits of COVID-19 Screening Tests with a Vaccine Rollout
Atkeson, A.; Droste, M. C.; Mina, M. J.; Stock, J.
Show abstract
This note estimates the costs and benefits of a nationwide COVID-19 screening testing program in the presence of vaccine distribution. Even for an optimistic vaccine rollout scenario, a well-designed federally-funded screening testing program, coupled with self-isolation of those who test positive, pays for itself in terms of increased GDP and is projected to save 20,000 or more lives. The sooner the testing program is put in place, the greater are its net economic benefits. This note updates the December 9, 2020 version to include updated deaths data, later dates for rolling out the screening testing program, and the spread of more contagious variants such as the B.1.1. 7 variant.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.